Use of Probiotics in Treatment and Rehabilitation of Patients after a New Coronavirus Infection

Abstract

As of January 2022, 343 million cases of SARS-CoV-2 were reported globally. COVID-19 is a multi-faceted, multi-systemic illness in whichall age groups are susceptible. A number of research findings have shown that COVID-19 is associated with dysbiosis, leading to thedevelopment of local and systemic pathologies. It was found that the use of probiotics in the complex therapy of patients with COVID-19 reduces the severity of the disease and the development of complications. According to the researchers, several mechanisms couldexplain the therapeutic effect of probiotics, including the ability to suppress pro-inflammatory cytokine formation and modulate thefunctional activity of the immune system. In Russia, probiotics in the treatment of COVID-19 patients are only used to correct diarrhea,while literature suggests that probiotics have much greater therapeutic potential. Introducing oral bacterial therapy into the treatmentand rehabilitation of COVID-19 patients requires further clinical trials.

Keywords

• as of january 2022
• 343 million cases of sars-cov-2 were reported globally. covid-19 is a multi-faceted
• multi-systemic illness in whichall age groups are susceptible. a number of research findings have shown that covid-19 is associated with dysbiosis
• leading to thedevelopment of local and systemic pathologies. it was found that the use of probiotics in the complex therapy of patients with covid-19 reduces the severity of the disease and the development of complications. according to the researchers
• several mechanisms couldexplain the therapeutic effect of probiotics
• including the ability to suppress pro-inflammatory cytokine formation and modulate thefunctional activity of the immune system. in russia
• probiotics in the treatment of covid-19 patients are only used to correct diarrhea
• while literature suggests that probiotics have much greater therapeutic potential. introducing oral bacterial therapy into the treatmentand rehabilitation of covid-19 patients requires further clinical trials